Advertisement

Topics

Oppenheimer & Co. Inc. Company Profile

20:28 EDT 22nd September 2017 | BioPortfolio


News Articles [21 Associated News Articles listed on BioPortfolio]

Incyte-Aktie: gebremster Enthusiasmus! - Aktienanalyse

New York - Incyte-Aktienanalyse des Analysten Jay Olson von Oppenheimer: Aktienanalyst Jay Olson vom Investmenthaus Oppenheimer rechnet laut einer aktuellen Aktienanalyse in Bezug auf die Aktien de...

Incyte-Aktie: Sorgt ASCO für mehr Klarheit? - Aktienanalyse

New York - Incyte-Aktienanalyse des Analysten Jay Olson von Oppenheimer: Aktienanalyst Jay Olson vom Investmenthaus Oppenheimer rechnet laut einer aktuellen Aktienanalyse in Bezug auf die Aktien de...

Oppenheimer startet Wal-Mart mit 'Outperform' - Ziel 90 US-Dollar

Die amerikanische Investmentbank Oppenheimer hat Wal-Mart mit "Outperform" und einem Kursziel von 90 US-Dollar in die Bewertung aufgenommen. Dies geht aus einer am Dienstag veröffentlichten Studie...

Apple-Aktie: Leaks trüben die Begeisterung empfindlich! - Aktienanalyse

New York - Apple-Aktienanalyse des Analysten Andrew Uerkwitz von Oppenheimer: Im Rahmen einer Aktienanalyse äußert Analyst Andrew Uerkwitz vom Investmenthaus Oppenheimer in Bezug auf die Aktien von....

Teva, Mylan Seen to Stay on M&A Sidelines

Teva is 'in no shape' to be making acquisitions while Mylan is 'still pretty leveraged,' says Oppenheimer analyst Derek Archila. Teva Pharmaceutical Industries Ltd. and Mylan NV will p...

Analysten bemängeln Informationspolitik von Apple - Aktienanalyse

New York - Apple-Aktienanalyse des Analysten Andrew Uerkwitz von Oppenheimer: Im Rahmen einer Aktienanalyse äußert Analyst Andrew Uerkwitz vom Investmenthaus Oppenheimer in Bezug auf die Aktien von....

Teva Pharmaceutical Industries Ltd (TEVA) Rating Reiterated by Oppenheimer Holdings Inc.

's stock had its "buy" rating restated by research analysts at Oppenheimer Holdings Inc. in a research report issued to clients and investors on Wednesday. Several other analysts have also recentl...

Amgen-Aktie: Vertrauen in Migräne-Medikament! - Aktienanalyse

New York - Amgen-Aktienanalyse der Analystin Leah Rush Cann von Oppenheimer: Die Aktienanalystin Leah Rush Cann vom Investmenthaus Oppenheimer äußert laut einer Aktienanalyse in Bezug auf die Aktie....

Drugs and Medications [0 Results]

None

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Cavity Born-Oppenheimer Approximation for Correlated Electron-Nuclear-Photon Systems.

In this work, we illustrate the recently introduced concept of the cavity Born-Oppenheimer approximation for correlated electron-nuclear-photon problems in detail. We demonstrate how an expansion in t...

Liberation of H2 from (o-C6H4Me)3P-H((+)) + ((-))H-B(p-C6F4H)3 ion-pair: A transition-state in the minimum energy path versus the transient species in Born-Oppenheimer molecular dynamics.

Using Born-Oppenheimer molecular dynamics (BOMD) with density functional theory, transition-state (TS) calculations, and the quantitative energy decomposition analysis (EDA), we examined the mechanism...

Efficient, "on-the-fly", Born-Oppenheimer and Car-Parrinello-type dynamics with coupled cluster (CCSD) accuracy through fragment based electronic structure.

We recently developed two fragment based ab initio molecular dynamics methods and in this publication we have demonstrated both approaches by constructing efficient classical trajectories in agreement...

Benchmark-Quality Atomization Energies for BeH and BeH2.

The total atomization energies for BeH and BeH2 have been calculated using the Feller-Peterson-Dixon approach to better than ±1 kcal/mol. The calculations are based on CCSD(T) all electron calculatio...

Constructive and Destructive Interferences in Nonadiabatic Tunneling via Conical Intersections.

As a manifestation of the molecular Ahanorov-Bohm effect, tunneling-facilitated dissociation under a conical intersection (CI) requires the inclusion of the geometric phase (GP) in order to ensure a s...

Clinical Trials [0 Results]

None

More Information about "Oppenheimer & Co. Inc." on BioPortfolio

We have published hundreds of Oppenheimer & Co. Inc. news stories on BioPortfolio along with dozens of Oppenheimer & Co. Inc. Clinical Trials and PubMed Articles about Oppenheimer & Co. Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oppenheimer & Co. Inc. Companies in our database. You can also find out about relevant Oppenheimer & Co. Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record